1. Leptomeningeal metastases: the future is now

   • Rimas V. Lukas
   • Jigisha P. Thakkar
   • Maciej S. Lesniak

   Topic Review 20 January 2022 Pages: 443 - 452

   

2. PD-L1 tumor expression is associated with poor prognosis and systemic immunosuppression in glioblastoma

   • Carolina Noronha
   • Ana Sofia Ribeiro
   • Joana Paredes

   Laboratory Investigation 23 January 2022 Pages: 453 - 464

   

3. Decision making and surgical modality selection in glioblastoma patients: an international multicenter survey

   • Jasper K. W. Gerritsen
   • Marike L. D. Broekman
   • Arnaud J. P. E. Vincent

   Clinical Study 24 January 2022 Pages: 465 - 482

   

4. Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study

   • Amir Massarweh
   • Roi Tschernichovsky
   • Shlomit Yust-Katz

   Clinical Study 12 January 2022 Pages: 483 - 489

   

5. Long term outcomes following surgery for pineal region tumors

   • Matthew J. Shepard
   • Ali S. Haider
   • Frederick F. Lang

   Clinical Study 27 January 2022 Pages: 491 - 498

   

6. Quality of life following concurrent temozolomide-based chemoradiation therapy or observation in low-grade glioma

   • Deborah Y. Park
   • Martin C. Tom
   • Erin S. Murphy

   Clinical Study 22 January 2022 Pages: 499 - 507

7. Stereotactic radiosurgery versus active surveillance for asymptomatic, skull-based meningiomas: an international, multicenter matched cohort study

   • Georgios Mantziaris
   • Stylianos Pikis
   • Jason Sheehan

   Clinical Study 24 January 2022 Pages: 509 - 518

   

8. Psychosocial profiles of risk and resiliency in neurofibromatoses: a person-centered analysis of illness adaptation

   • Sarah M. Bannon
   • Sarah W. Hopkins
   • Ana-Maria Vranceanu

   Clinical Study 22 January 2022 Pages: 519 - 527

9. Cranial sonolucent prosthesis: a window of opportunity for neuro-oncology (and neuro-surgery)

   • Massimiliano Del Bene
   • Luca Raspagliesi
   • Francesco DiMeco

   Clinical Study 26 January 2022 Pages: 529 - 540

   

10. Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma

    • Yong-Pyo Lee
    • Hyun Ae Jung
    • Se-Hoon Lee

    Clinical Study 30 January 2022 Pages: 541 - 549

    

11. The clinical characteristics and outcomes of incidentally discovered glioblastoma

    • Daisuke Kawauchi
    • Makoto Ohno
    • Yoshitaka Narita

    Clinical Study 05 January 2022 Pages: 551 - 557

    

12. Diagnostic value of ¹⁸F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients

    • Ritch T. J. Geitenbeek
    • Enrico Martin
    • Walter Taal

    Clinical Study Open access 13 January 2022 Pages: 559 - 567

    

13. Inter-fraction dynamics during post-operative 5 fraction cavity hypofractionated stereotactic radiotherapy with a MR LINAC: a prospective serial imaging study

    • Hendrick Tan
    • James Stewart
    • Hany Soliman

    Clinical Study 03 January 2022 Pages: 569 - 577

    

14. Predicting survival in patients with glioblastoma using MRI radiomic features extracted from radiation planning volumes

    • Benjamin J. Geraghty
    • Archya Dasgupta
    • Gregory J. Czarnota

    Clinical Study 03 January 2022 Pages: 579 - 588

    

15. Tumor load rather than contrast enhancement is associated with the visual function of children and adolescents with optic pathway glioma – a retrospective Magnetic Resonance Imaging study

    • Anna Kilian
    • Annette Aigner
    • Anna Tietze

    Clinical Study Open access 07 January 2022 Pages: 589 - 597

    

16. Final results of the Choroid Plexus Tumor study CPT-SIOP-2000

    • Johannes E. Wolff
    • Stefaan W. Van Gool
    • Uwe R. Kordes

    Clinical Study Open access 08 January 2022 Pages: 599 - 613

    

17. Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients

    • Stéphan Grimaldi
    • Vincent Harlay
    • Emeline Tabouret

    Clinical Study 07 January 2022 Pages: 615 - 623

    

18. Temozolomide-induced myelotoxicity and single nucleotide polymorphisms in the MGMT gene in patients with adult diffuse glioma: a single-institutional pharmacogenetic study

    • Prithwijit Moitra
    • Abhishek Chatterjee
    • Tejpal Gupta

    Clinical Study 17 January 2022 Pages: 625 - 634

    

19. Endoscopic-assisted surgical approach for butterfly glioma surgery

    • Nicholas B. Dadario
    • Ashraf Zaman
    • Charles Teo

    Clinical Study 15 January 2022 Pages: 635 - 644

    

20. MR susceptibility imaging for detection of tumor-associated macrophages in glioblastoma

    • Amir Nazem
    • Samantha C. Guiry
    • Ali Nabavizadeh

    Clinical Study 19 January 2022 Pages: 645 - 653